The antiphospholipid syndrome (APS) is defined by the occurrence of venous and arterial
thromboses, often multiple, and recurrent fetal losses, frequently accompanied by a …

The antiphospholipid syndrome (APS) is defined by the development of venous and/or
arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses) …

Background: The biological diagnostics of antiphospholipid syndrome (APS) takes into
account the persistent positivity for anticardiolipin and/or anti-β2GP1 antibodies and/or …

Essentials• The clinical value of IgM antibodies in thrombotic antiphospholipid syndrome
(APS) is debated.• By review of literature, we reconsidered the clinical value of IgM …

We previously reported that treatment of mice with 6-gingerol, the most abundant
phytochemical in ginger root, leads to phosphodiesterase inhibition that counteracts …

Objective. Associations between autoantibodies and clinical features have been described
in systemic lupus erythematosus (SLE). Herein, we aimed to define autoantibody clusters …

Objective. To assess the longterm frequency of thrombotic recurrences, obstetrical
complications, organ damage, severe comorbidities, and evolution toward connective tissue …

Antiphospholipid syndrome (APS) has been characterized by a variety of vascular and
pregnancy manifestations related to an interplay between thrombotic and inflammatory …

Introduction In antiphospholipid syndrome (APS), certain principal manifestations are
associated with a worse prognosis and organ damage. Objective The objective of this paper …

Background Antiphospholipid syndrome (APS) is an acquired hypercoagulable condition
associated with antiphospholipid antibody (aPL) presence. Data on re-thrombosis following …